BDBM181729 US9676728, 4 (-)-2-(1-(3-bromo-6-methoxy-2,4-dimethylphenyl)-2,2,2-trifluoro-1-hydroxyethyl)-1H-benzo[d]imidazole-5-carbonitrile

SMILES COc1cc(C)c(Br)c(C)c1C(O)(c1nc2cc(ccc2[nH]1)C#N)C(F)(F)F

InChI Key InChIKey=AFHFTTWQEBAOCK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 181729   

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM181729(US9676728, 4 (-)-2-(1-(3-bromo-6-methoxy-2,4-dimet...)
Affinity DataIC50: 9.89E+4nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
Go to US Patent